| ELTX:Elicio Therapeutics Inc | | Charting | News | Options | |||||||||||||
| ||||||||||||||
| ||||||||||||||
| ||||||||||||||
37.35% $1.92
 Markets |
 Portfolio |
| |
| |
|
| |
|
|
|
|||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||
|
| Latest Story |
|
| Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Stockholders to Inquire about Securities Investigation |
|
| ACCESSWIRE |
|
NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elicio Therapeutics, Inc. ("Elicio" or "the Company") (NASDAQ:ELTX). Investors who purchased Elicio securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ELTX. |
| Full Story → |
|
| Headline News |
|
| Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering |
| 12:25a ET July 2 '26 GlobeNewswire |
|
|
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Investors to Learn More About the Investigation |
| 11:00a ET July 1 '26 ACCESSWIRE |
|
|
| Elicio Therapeutics Added to Russell 2000(R) and Russell 3000(R) Indexes |
| 8:00a ET June 29 '26 GlobeNewswire |
|
| More News → |
| ||
|
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| July 2 '26. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Previous data from yesterday, July 1 '26. | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| Historical Price Performance | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Market data provided by 
News provided by   |
